SEARCH

SEARCH BY CITATION

References

  • Al-Shammari KF, Giannobile WV, Aldredge WA, Iacono VJ, Eber RM, Wang HL & Oringer RJ (2001) Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels. J Periodontol 72: 10451051.
  • Aurer A, Jorgic-Srdjak K, Plancak D, Stavljenic-Rukavina A & Aurer-Kozelj J (2005) Proinflammatory factors in saliva as possible markers for periodontal disease. Coll Antropol 29: 435439.
  • Balbin M, Hall A, Grubb A, Mason RW, Lopez-Otin C & Abrahamson M (1994) Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases. J Biol Chem 269: 2315623162.
  • Baron AC, Gansky SA, Ryder MI & Featherstone JD (1999) Cysteine protease inhibitory activity and levels of salivary cystatins in whole saliva of periodontally diseased patients. J Periodontal Res 34: 437444.
  • Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD & Christiansen C (1997) Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 12: 10281034.
  • Bowers MR, Fisher LW, Termine JD & Somerman MJ (1989) Connective tissue-associated proteins in crevicular fluid: potential markers for periodontal diseases. J Periodontol 60: 448451.
  • Curby WA (1953) Device for collection of parotid saliva. J Lab Clin Med 41: 493496.
  • Delmas PD (1993) Biochemical markers of bone turnover. J Bone Miner Res (Suppl 2), S549555.
  • Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP & Williams RC (1995) Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J Clin Periodontol 22: 903910.
  • Giannopoulou C, DiFelice R, Andersen E & Cimasoni G (1990) Synthesis of alpha 2-macroglobulin in human gingiva: a study of the concentration of macroglobulin and albumin in gingival fluid and serum. Arch Oral Biol 35: 1316.
  • Ginsburg KA, Wolf NA & Fidel PL (1997) Potential effects of midcycle cervical mucus on mediators of immune reactivity. Fertil Steril 67: 4650.
  • Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T & Giannobile WV (1997) A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 46: 310319.
  • Hausmann E, Allen K & Clerehugh V (1991) What alveolar crest level on a bite-wing radiograph represents bone loss? J Periodontol 62: 570572.
  • Heasman PA, Collins JG & Offenbacher S (1993) Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Perio Res 28: 241247.
  • Hildebolt CF (1997) Osteoporosis and oral bone loss. Dentomaxillofac Radiol 26: 315.
  • Ingman T, Sorsa T, Konttinen YT, Liede K, Saari H, Lindy O & Suomalainen K (1993) Salivary collagenase, elastase- and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis. Oral Microbiol Immunol 8: 298305.
  • Iontcheva I, Oppenheim FG & Troxler RF (1997) Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins. J Dent Res 76: 734743.
  • Kornman KS, Page RC & Tonetti MS (1997) The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14: 3353.
  • Mandel ID & Wotman S (1976) The salivary secretions in health and disease. Oral Sci Rev 2547.
  • Masada MP, Persson R, Kenney JS, Lee SW, Page RC & Allison AC (1990) Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodontal Res 25: 156163.
  • Miller CS, King CP Jr, Langub MC, Kryscio RJ & Thomas MV (2006) Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 137: 322329.
  • Nakamura M & Slots J (1983) Salivary enzymes. Origin and relationship to periodontal disease. J Periodon Res 18: 559569.
  • Nakashima K, Giannopoulou C, Andersen E, Roehrich N, Brochut P, Dubrez B & Cimasoni G (1996) A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 23: 832838.
  • Nomura S, Wills AJ, Edwards DR, Heath JK & Hogan BL (1988) Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 106: 441450.
  • Offenbacher S (1996) Periodontal diseases: pathogenesis. Ann Periodontol 1: 821878.
  • Oringer RJ, Palys MD, Iranmanesh A, Fiorellini JP, Haffajee AD, Socransky SS & Giannobile WV (1998) C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Implants Res 9: 365373.
  • Page RC (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26: 230242.
  • Palomo L, Bissada NF & Liu J (2005) Periodontal assessment of postmenopausal women receiving risedronate. Menopause 12: 685690.
  • Reinhardt RA, Masada MP, Kaldahl WB, DuBois LM, Kornman KS, Choi JI, Kalkwarf KL & Allison AC (1993) Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 20: 225231.
  • Rossomando EF, Kennedy JE & Hadjimichael J (1990) Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 35: 431434.
  • Stashenko P, Dewhirst FE, Peros WJ, Kent RL & Ago JM (1987) Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138: 14641468.
  • Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J & Socransky SS (1991) Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 62: 504509.
  • Taba M Jr, Kinney J, Kim AS & Giannobile WV (2005) Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am 49: 55157.
  • Tabak LA (1995) In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. Ann Rev Physiol 57: 547564.
  • Talonpoika JT & Hamalainen MM (1994) Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol 21: 320326.
  • Tatakis DN (1993) Interleukin-1 and bone metabolism: a review. J Periodontol 64: 416431.
  • Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML & Martin GR (1981) Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26: 99105.
  • Tomar SL & Asma S (2000) Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 71: 743751.
  • Vignali DA (2000) Multiplexed particle-based flow cytometric assays. J Immunol Methods 243: 243255.
  • Wozniak KL, Arribas A, Leigh JE & Fidel PL Jr (2002) Inhibitory effects of whole and parotid saliva on immunomodulators. Oral Microbiol Immunol 17: 100107.
  • Zambon JJ, Nakamura M & Slots J (1985) Effect of periodontal therapy on salivary enzymatic activity. J Periodontal Res 20: 652659.